KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adient (ADNT) EBT (2016 - 2025)

Adient (ADNT) has disclosed EBT for 11 consecutive years, with $41.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 12.77% year-over-year to $41.0 million, compared with a TTM value of -$94.0 million through Dec 2025, down 181.74%, and an annual FY2025 reading of -$88.0 million, down 166.17% over the prior year.
  • EBT was $41.0 million for Q4 2025 at Adient, down from $64.0 million in the prior quarter.
  • Across five years, EBT topped out at $1.1 billion in Q3 2021 and bottomed at -$265.0 million in Q1 2025.
  • Average EBT over 5 years is $86.8 million, with a median of $64.0 million recorded in 2022.
  • The sharpest move saw EBT surged 3527.27% in 2021, then plummeted 546.34% in 2025.
  • Year by year, EBT stood at -$9.0 million in 2021, then soared by 811.11% to $64.0 million in 2022, then increased by 1.56% to $65.0 million in 2023, then fell by 27.69% to $47.0 million in 2024, then fell by 12.77% to $41.0 million in 2025.
  • Business Quant data shows EBT for ADNT at $41.0 million in Q4 2025, $64.0 million in Q3 2025, and $66.0 million in Q2 2025.